(R,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
99%
- Product Code: 37788
CAS:
945553-91-3
| Molecular Weight: | 485.9384 g./mol | Molecular Formula: | C₂₄H₂₅ClFN₅O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a potent inhibitor targeting specific tyrosine kinases, which are enzymes involved in the regulation of cellular processes such as growth, differentiation, and survival. By inhibiting these kinases, the compound can potentially disrupt signaling pathways that contribute to the proliferation of cancer cells. It is often studied for its efficacy in treating various types of cancers, particularly those driven by mutations or overactivity in kinase signaling pathways. Researchers also explore its potential in combination therapies to enhance the effectiveness of existing cancer treatments. Additionally, its structure allows for modifications to improve pharmacokinetic properties, such as bioavailability and metabolic stability, making it a promising candidate for drug development.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | Ft158,056.16 |
+
-
|
(R,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a potent inhibitor targeting specific tyrosine kinases, which are enzymes involved in the regulation of cellular processes such as growth, differentiation, and survival. By inhibiting these kinases, the compound can potentially disrupt signaling pathways that contribute to the proliferation of cancer cells. It is often studied for its efficacy in treating various types of cancers, particularly those driven by mutations or overactivity in kinase signaling pathways. Researchers also explore its potential in combination therapies to enhance the effectiveness of existing cancer treatments. Additionally, its structure allows for modifications to improve pharmacokinetic properties, such as bioavailability and metabolic stability, making it a promising candidate for drug development.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :